Bridgewater Associates’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,533
| Closed | -$537K | – | 757 |
|
|
2024
Q3 | $537K | Sell |
29,533
-83,807
| -74% | -$1.52M | ﹤0.01% | 683 |
|
|
2024
Q2 | $3.3M | Buy |
113,340
+46,720
| +70% | +$1.36M | 0.02% | 438 |
|
|
2024
Q1 | $2.36M | Sell |
66,620
-9,754
| -13% | -$346K | 0.01% | 474 |
|
|
2023
Q4 | $3.33M | Sell |
76,374
-11,791
| -13% | -$513K | 0.02% | 432 |
|
|
2023
Q3 | $3.37M | Buy |
88,165
+6,257
| +8% | +$239K | 0.02% | 418 |
|
|
2023
Q2 | $3.37M | Sell |
81,908
-8,180
| -9% | -$336K | 0.02% | 381 |
|
|
2023
Q1 | $5.17M | Buy |
90,088
+4,051
| +5% | +$233K | 0.03% | 304 |
|
|
2022
Q4 | $4.82M | Sell |
86,037
-29,470
| -26% | -$1.65M | 0.03% | 368 |
|
|
2022
Q3 | $4.89M | Buy |
115,507
+424
| +0.4% | +$18K | 0.02% | 383 |
|
|
2022
Q2 | $6.22M | Buy |
115,083
+10,810
| +10% | +$584K | 0.03% | 440 |
|
|
2022
Q1 | $6.7M | Buy |
104,273
+23,292
| +29% | +$1.5M | 0.03% | 387 |
|
|
2021
Q4 | $5.43M | Buy |
80,981
+6,018
| +8% | +$403K | 0.03% | 276 |
|
|
2021
Q3 | $5.13M | Buy |
74,963
+5,081
| +7% | +$348K | 0.03% | 285 |
|
|
2021
Q2 | $4.77M | Buy |
+69,882
| New | +$4.77M | 0.03% | 337 |
|